Paylean™ (ractopamine hydrochloride)

A uniform finish

Hemicell™ (β-Mannanase)

The unique energy sparing enzyme
Hemicell™ Supreme

Hemicell™ Supreme (β-mannanase)

The Unique Energy Sparing Enzyme

Flubenol™ (flubendazole)

Tylan™ 250 Premix

Tylan™ 250 Premix (tylosin phosphate)


Pulmotil™ (tilmicosin phosphate)

Tylan 200 Injection

Tylan™ 200 Injection (tylosin injection)

Porcine Pilishield

Porcine Pili Shield™ (Escherichia coli Bacterin)

Improve herd performance and profitability

Tylan™ 200 Injection (tylosin injection)
Tylan™ 200 Injection (tylosin injection)

Tylan™ 200 Injection

This is a restricted veterinary medicine. This product is only available under veterinary authorisation. Tylan™ 200 Injection posses a wide spectrum of antibiotic activity and is active against gram positive bacteria including Staphylococci, Corynebacteria spp. and Erysipelothrix rhuslopathiae (insidiosa). It is also active against certain gram negative bacteria, eg. Lawsonia intracellularis and certain spirochaetes. It has been found to be extremely active against Mycoplasma species isolated from both avian and mammalian hosts including pigs, cattle, sheep and goats.

Important Safety Information

It is an offence for users of this product to cause residues exceeding the relevant MRL in the NZ (Maximum Residues of Agricultural Compounds) Food Standard.

Withholding Periods

MEAT: Animals producing meat and offal for human consumption must not be sold for slaughter either during treatment or within 21 days of last treatment

MILK: Milk intended for sale for human consumption or manufacture for human consumption must be discarded during treatment and for 72 hours following the last treatment.

The administration of antibiotics may result in the overgrowth of non-susceptible organisms. If new infections due to bacteria and fungi appear during therapy with this drug appropriate measures should be taken. Do not mix Tylan™ 200 Injection with other parenteral solutions, as this may cause a precipitate of the active ingredient.

Directions For Use

Success with Tylan™ 200 Injection has been reported for the control of the following disease conditions:

PIGS: swine dysentery and enteritis associated with the presence of Lawsonia intracellularis and other organisms sensitive to tylosin, swine erysipelas, pneumonia and arthritis due to Mycoplasma.

CATTLE: respiratory infections, foot rot (necrotic pododermatitis), calf diphtheria, metritis and acute mastitis.

SHEEP AND GOATS: the treatment of the early stages of the peracute and acute forms of contagious agalactia caused by Mycoplasma agalactiae and caprine pleuropneumonia caused by Mycoplasma mycoides var Capri (M. Capri)

Dosage and Administration

Tylan™ 200 Injection should be used by intramuscular or slow intravenous injection in cattle only. Rapid intravenous injection may cause ataxia, dyspnoea and increased salivation. Intramuscular injections to be given into the anterior half of the neck. A dry hypodermic needle and syringe should be used where possible. It is advisable to alternate the injection site when repeated daily doses are given. Doses over 15ml should be in different sites.

PIGS: 5 to 10 mg/kg body weight intramuscularly daily. Do not exceed 3 days of treatment.

CATTLE AND CALVES: 5 to 10 mg/kg body weight intramuscularly daily or by the SLOW intravenous route (Follow intravenous dose with intramuscular dose 12 hours later to maintain therapeutic levels). Do not exceed 5 days of treatment.

SHEEP AND GOATS: 5 to 10mg/kg body weight intramuscularly daily. Do not exceed 5 days treatment.


If there is no response to therapy within 3 to 5 days, the diagnosis and treatment should be re-assessed. The prophylactic and therapeutic use of this product should only be for the minimum period needed to meet the clinical objective. Indiscriminate use of this product could contribute to antibiotic resistance.


Registered pursuant to the ACVM Act 1997, No. A907.
See for registration conditions